XiltriX North America, LLC — Form D
XiltriX North America, LLC of SAN DIEGO, CA, a company, filed a Form D exempt-offering notice with the SEC on 2024-02-14. The offering totals $2.5M, of which $2.5M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2024-02-14
- Form: D
- Accession: 0001777611-24-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $2.5M
- Amount sold: $2.5M
- Investors: 18
- Date of first sale: 2024-02-08
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-505253
Issuer
- Name: XiltriX North America, LLC
- CIK: 0001777611
- Entity type: Limited Liability Company
- Jurisdiction: DELAWARE
- Incorporated: 2018
- Address: 4660 LA JOLLA VILLAGE DR., SUITE 100, SAN DIEGO, CA, 92122
- Phone: 858-535-4820
Officers, directors & promoters (7)
| Name | Role | Location |
|---|
| Hendrik Hanselaar | Director | San Diego, CA |
| Erik van Stek | Director | San Diego, CA |
| Michael O'Connell | Director | San Diego, CA |
| Nathaniel Paige | Director | San Diego, CA |
| Moises Eilemberg | Director | San Diego, CA |
| Moises Eilemberg | Executive Officer | San Diego, CA |
| Stephen Tierney | Executive Officer | San Diego, CA |
Other filings by this issuer (6)
More